personal scheduler Hamburg 2013 - Main Site Press Release 2013 Call for Abstracts General Information Programme Overview Letter from the President Keynote Lectures Main Sessions NEW - Free Paper Session Instructional Courses World Retina Day Retinal Detachment Course Uveitis Course Other Symposia Surgical Skills Training Courses
hamburg banner

Vascular endothelial growth factor in Coats' disease

Session Details

Session Title: Vascular Diseases III

Session Date/Time: Sunday 29/09/2013 | 08:00-10:00

Paper Time: 09:44

Venue: Hall 3 (Level 0)

First Author: Q.Zhao CHINA

Co Author(s):    X. Peng   F. Chen   Y. Zhang   L. Wang     

Abstract Details


To examine whether vascular endothelial growth factor (VEGF) as one of the most important intraocular cytokines for angiogenesis and increased vascular permeability is associated with Coats` disease.


Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Science Key Lab, Beijing, China.


The clinical interventional study included 28 patients with Coats` disease and 7 control patients with congenital cataract. During intraocular surgery, we obtained aqueous humor samples in which the VEGF concentration was measured by double antibody sandwich enzyme-linked immunosorbent assay (ELISA). Coats` disease was graded into 4 stages.


The mean aqueous VEGF level was significantly higher in the Coats` study group than in the control group (158±88pg/mL versus 97±21pg/mL; P=0.002). The VEGF concentrations increased significantly (P<0.001) from 91±32pg/mL in Coats` disease stage 2 to 100±37pg/mL in stage 3A1, 185±56pg/mL in stage 3A2 to 256±93pg/mL in patients with stage 3B. VEGF concentrations in Coats` stage 2 and 3A1 did not differ significantly from the values in the control group. Parallel to the association with the stage of the diseases, the VEGF concentrations were significantly (P<0.001) correlated with extent of exudative retinal detachment.


Increasing severity of Coats` disease is significantly associated with intraocular VEGF concentrations. These results favor the intravitreal application of anti-VEGF drugs as medical therapy of Coats` diseases.

Back to Freepaper Session
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email:

Privacy policyHotel Terms and Conditions Cancellation policy